Well Referenced

Tag: teratogenicity

Phentermine/Topiramate Extended-Release Capsules (Qsymia) for Weight Loss

This 2013 review evaluates the efficacy and safety of phentermine/topiramate extended-release (PHEN/TPM ER) capsules, marketed as Qsymia, for obesity management. Clinical trials demonstrated significant weight loss ranging from 8.1% to 10.9% with mid to high doses, compared to 1.4% to 1.8% with placebo. PHEN/TPM ER also led to reductions in

June 26, 2025 No Comments

Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date

This systematic review investigates the efficacy, mechanism, and safety profile of finasteride in treating female pattern hair loss (FPHL), exploring both oral and topical formulations as well as the use of dutasteride, another 5α-reductase inhibitor. The review highlights finasteride’s ability to promote hair regrowth and improve hair density by inhibiting

June 26, 2025 No Comments